title: The relationship between apolipoprotein E, dementia, and vascular illness.
abstract: The purpose of this study was to concurrently assess the relationship of Apolipoprotein E (APOE) with both dementias and vascular illnesses in the very old. Nine hundred and fifty nine subjects (mean age 85 years) in a long-term care facility were genotyped and cognitively tested with the Mini Mental State Exam. All subjects were studied for the relationship of APOE with atherosclerotic heart disease, hypertension, or stroke without concomitant dementia. Four hundred fifty individuals met criteria for inclusion into one of the following groups: Alzheimer's disease (n = 318), vascular dementia (n = 49), or not demented controls (n = 83) and were investigated for the relationship between APOE and these diagnostic categories. APOE epsilon4 was not associated with atherosclerotic heart disease, hypertension, or stroke without concomitant dementia. The APOE epsilon3 allele was more common in men with atherosclerotic heart disease. In contrast, the APOE epsilon4 allele was more common in patients with Alzheimer's disease (22%) and vascular dementia (26%) than in not demented controls (7%). APOE epsilon4 is associated with dementias in the very old, whereas its relationship with either peripheral or central nervous system vascular disease without dementia is not as robust.
authors.affiliation: Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA. deborah.marin@doc.mssm.edu
authors.forename: D B
authors.initials: DB
authors.lastname: Marin
authors.forename: B
authors.initials: B
authors.lastname: Breuer
authors.forename: M L
authors.initials: ML
authors.lastname: Marin
authors.forename: J
authors.initials: J
authors.lastname: Silverman
authors.forename: J
authors.initials: J
authors.lastname: Schmeidler
authors.forename: D
authors.initials: D
authors.lastname: Greenberg
authors.forename: S
authors.initials: S
authors.lastname: Flynn
authors.forename: M
authors.initials: M
authors.lastname: Mare
authors.forename: M
authors.initials: M
authors.lastname: Lantz
authors.forename: L
authors.initials: L
authors.lastname: Libow
authors.forename: R
authors.initials: R
authors.lastname: Neufeld
authors.forename: L
authors.initials: L
authors.lastname: Altstiel
authors.forename: K L
authors.initials: KL
authors.lastname: Davis
authors.forename: R C
authors.initials: RC
authors.lastname: Mohs
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D000544:Alzheimer Disease / Q000097:blood / Q000235:genetics; D053329:Apolipoprotein E2; D053318:Apolipoprotein E3; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000097:blood* / Q000235:genetics*; D001161:Arteriosclerosis / Q000097:blood* / Q000235:genetics*; D002545:Brain Ischemia / Q000097:blood* / Q000235:genetics*; D015140:Dementia, Vascular / Q000097:blood* / Q000235:genetics*; D005260:Female; D016330:Frail Elderly; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000235:genetics*; D008297:Male
chemical_list: D053329:Apolipoprotein E2; D053318:Apolipoprotein E3; D053327:Apolipoprotein E4; D001057:Apolipoproteins E